Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Warningtitle
SDS
Charter Link Accessibility

There are multiple referential links provided within this charter. Some of the associated links are public, but others (i.e., with an asterisk*) are limited to SDS team members. If you wish to join the SDS team as a volunteer, please visit this page here to get started.

Leadership Team
  • Kristin Kelly
  • Soumya Rajesh
  • Maria Sekac
  • Dianna DiRusso (Project Manager
SDS Leadership Team
  • Janet Reich (Current - 2019)
  • Mike Hamidi (Future - 2020)
  • Christine Connolly (Future - 2021
    • )
    SDS Sub-team Leaders

    Team leaders are listed in the SDS

    sub-teams and collaborations table

    Subteam Tracker.

    SDS Team Liaisons to the GGG

  • Kristin Kelly
  • Ellina Babouchkina

  • Susan Tierney
    • Gary Walker
    • Michael Wise

    • Dave Scocca

    Deliverables
    • Study Data Tabulation Model Implementation Guide (SDTMIG): Human Clinical Trials
    • SDTMIG Conformance Rules
    • SDTMIG for Associated Persons (AP)

    • SDTMIG for Medical Devices (MD)

  • SDTMIG for Pharmacogenomic/genetics (PGx)
    • Metadata Submission Guidelines (MSG) for SDTMIG
    • Oncology Supplements

    • Questionnaires, Ratings, Scales (QRS) Supplements





    .

    Team Mission

    The SDS team develops and maintains standards for representing study data from human clinical trials and other research collaborations. The SDS team seeks continuous improvement and strives to increase the value of standardized study data for greater interoperability and accessibility by academic researchers, healthcare organizations, sponsors, and global health authorities.

    Scope

    The SDS team scope focuses on SDTM implementation guides for human clinical trial data. Each implementation guide (and its associated SDTM) describes the organization, structure, and format of the standardized data to support use by academic researchers, healthcare organizations, sponsors, and/or global health authorities.

    Operating Model
    • Working meetings to plan for future projects and content for industry stakeholders
    • A predictable and open forum for SDS team members to raise concerns/issues, provide feedback, identify cross-standard discrepancies (e.g., CDASH, CT), propose solutions, support development of content, and aid in the review and disposition of content for publication
    • Communicate across and manage all associated SDS sub-teams
    • Provide the Global Governance Group (GGG) updates to the wider SDS team members
    • Aid in on-boarding and mentoring SDS volunteers by providing a transparent and inclusive development culture
    Additional Resources
  • CDISC Website
  • CDISC Wiki
  • SDS Landing Page*
  • Technical Leadership Committee*

  • Global Governance Group Home*

  • Standards Updates Table*

    Navigating the CDISC Standards Development Process*

    Stakeholders
    • Regulatory Authorities (e.g., U.S. FDA, PMDA)
    • Standards & Related Organizations (e.g., HL7, LOINC, WHO, UMC, PhUSE)
    • Pharmaceutical/Biotech, Medical Devices,
    Real World Devices
    • etc.
    • Contract Research Organizations
    Software Development Organizations
    • (CROs)
    • Technology Vendors
    • Consultants, Programmers, Statisticians, and other related Subject Matter Experts
    • Academic and Scientific Communities
    • Healthcare
    Organizations
    • Institutions
    Cross-Team Collaborations

    The SDS team works closely across CDISC teams to ensure consistency, clarity, and to support development requirements of SDS deliverables.

    A list of cross-team collaborations (and SDS subteams) are listed on the SDS Home page.

    Additional Resources
    Home page

    *Links are accessible to CDISC Volunteers only.

    .